Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections
Li, Baoli2; Ni, Shuaishuai2; Chen, Feifei1; Mao, Fei2; Wei, Hanwen2; Liu, Yifu2; Zhu, Jin2; Lan, Lefu1; Li, Jian2
刊名ACS INFECTIOUS DISEASES
2018-03
卷号4期号:3页码:208-217
关键词Staphylococcus aureus diapophytoene desaturase methicillin-resistant Staphylococcus aureus hERG safety
ISSN号2373-8227
DOI10.1021/acsinfecdis.7b00259
文献子类Article
英文摘要Blocking the biosynthesis process of staphyloxanthin has emerged as a promising antivirulence strategy. Our previous research revealed that diapophytoene desaturase was an attractive and druggable target against infections caused by pigmented Staphylococcus aureus. Benzocycloalkane-derived compounds were effective inhibitors of diapophytoene desaturase but limited by high hERG (human Ether-a-go-go Related Gene) inhibition activity. Here, we identified a new type of benzo-hepta-containing cycloalkane derivative as diapophytoene desaturase inhibitors. Among the fifty-eight analogues, 48 (hERG inhibition activity, half maximal inhibitory concentration, IC50, of 16.1 mu M) and 51 (hERG inhibition activity, IC50 > 40 mu M) were distinguished for effectively inhibiting the pigment production of Staphylococcus aureus Newman and three methicillin-resistant Staphylococcus aureus strains, and the four strains were highly sensitize to hydrogen peroxide killing without a bactericidal growth effect. In an in vivo assay, 48 and 51 displayed a comparable effect with linezolid and vancomycin in livers and hearts in mice against Staphylococcus aureus Newman and a more considerable effect against Mu50 and NRS271 with normal administration.
资助项目National Key R&D Program of China[2017YFB0202600] ; National Natural Science Foundation of China[21672064] ; "Shu Guang" project - Shanghai Municipal Education Commission[00000000] ; "Shu Guang" project - Shanghai Education Development Foundation[14SG28] ; Fundamental Research Funds for the Central Universities[00000000]
WOS关键词RESISTANT STAPHYLOCOCCUS-AUREUS ; VIRULENCE ; BIOSYNTHESIS ; STAPHYLOXANTHIN ; NEUTROPHILS ; EPIDEMIC ; CRTN
WOS研究方向Pharmacology & Pharmacy ; Infectious Diseases
语种英语
出版者AMER CHEMICAL SOC
WOS记录号WOS:000427443200001
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/279865]  
专题药理学第三研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Lan, Lefu; Li, Jian
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 646 Songtao Rd, Shanghai 201203, Peoples R China
2.East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, 130 Meilong Rd, Shanghai 200237, Peoples R China;
推荐引用方式
GB/T 7714
Li, Baoli,Ni, Shuaishuai,Chen, Feifei,et al. Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections[J]. ACS INFECTIOUS DISEASES,2018,4(3):208-217.
APA Li, Baoli.,Ni, Shuaishuai.,Chen, Feifei.,Mao, Fei.,Wei, Hanwen.,...&Li, Jian.(2018).Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections.ACS INFECTIOUS DISEASES,4(3),208-217.
MLA Li, Baoli,et al."Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections".ACS INFECTIOUS DISEASES 4.3(2018):208-217.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace